How to Target the Right Physicians Using Trigger Programs
As therapies become increasingly complex and personalized, it is imperative that physicians...
4 minute read
The Path Forward: Revealing the Rare Disease Patient Journey
While each rare disease individually impacts only 200,000 people or less, with 7,000 known rare...
4 minute read
Demonstrating the Value of Digital Health Post Pandemic
As life settles into the new normal after the worst of the COVID-19 pandemic, it is clear that...
4 minute read
The Fight Continues: Battling the COVID Evolution
While it feels like we’re back to a pre-pandemic sense of normal, COVID continues to be an evolving...
1 minute read
A Ready-Made Solution for Accelerating RSV Research
With the surge in RSV cases that plagued our nation’s children at record levels this fall and over...
2 minute read
Lessons Learned from COVID-19 Clinical Trials
The challenges of the COVID-19 pandemic did bring about some positive impact, accelerating the...
4 minute read
Four Steps to Linking Clinical Trial and Real-World Data
Historically, clinical trial data and real-world data (RWD) have existed in silos. With increasing...
3 minute read
Four Ways Lab Data Can Enhance Clinical Research
A recent survey by the Deloitte Center for Health Solutions of biopharma executives and other...
3 minute read
Diversity on demand: How to meet new FDA guidance for clinical trials
The FDA recently released draft guidance that provides details on creating Diversity Action Plans (DAPs) for clinical trials. This is part of a continuing effort to address ongoing challenges in broadening diversity and ensuring that clinical trials ...
- Solutions & Best Practices
- R&D
- HEOR by:HealthVerity on: March 28, 2023